iSelect’s unhealthy first strike

Health insurance comparison website, iSelect (ASX: ISU) has received a first strike against its executive pay.

Shareholders were obviously not amused that the company dropped its prospectus forecasts and didn’t pay any dividends, yet the company paid its executives bonuses. The company has been beset by problems since listing.  Shares have dived to trade at just $1.21, a 35% fall from the IPO price of $1.85, CEO Matt McCann quit in October, after the company missed its revenue forecast of $121.6 million by $3.6 million, and iSelect founder Damien Waller has been called to stand down.

Not only that, but major shareholder Spectrum Equity Investors sold most of its 8% stake unexpectedly on the company’s first day of trading, and revenue for the full 2013 year has been lowered to $126.5 million.

An investigation by corporate teddy bear, the Australian Securities and Investments Commission (ASIC) let the company off the hook, saying it would not be taking further action over allegations that iSelect failed to meet its continuous disclosure obligations.

The Australian Shareholders Association (ASA) urged shareholders to vote against the remuneration report, and vote they did with 27.5% of shareholders rejecting the remuneration report. As more than 25% of shareholders voted against it, iSelect has received its first strike. Should it happen again next year, under ‘second strike’ rules the board must all re-stand for election, potentially triggering a board spill.

Compared to other recent IPOs such as Virtus Health (ASX: VRT), OzForex (ASX: OFX) and (ASX: FLN), iSelect has been a disappointing IPO. Questions were raised over its revenue recognition accounting practices, as well as the company’s whole business model. There are a multitude of websites offering similar services to iSelect, suggesting the company has no real competitive advantage.

Foolish takeaway

Foolish investors may want to steer clear of the company until the dust settles and iSelect can prove that it has a valid business model. So far, it’s not looking good.

It's not a recent IPO and has a clear policy of paying regular dividends. Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

Motley Fool writer/analyst Mike King doesn’t own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.